Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673059 · ClinicalTrials.gov registry record · NA
Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch
A NA study of Microbiota, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 2
- Study locations
NCT03673059 is a NA study of Microbiota that has completed, run by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies. The registered enrollment target is 91 participants, below the 130-participant average among 10 other Microbiota trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03673059, a NA study of Microbiota, has completed, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 2
- Study locations
Study Summary
This was a multi-center, 14-day clinical use study with a 7-day regression period, being conducted to assess the changes in the skin microbiome with two moisturizers in female and male subjects 16-50 years of age with mild to moderate eczema that experienced a recent itch flare up.
Conditions Studied
Interventions
- DRUG OTC Eczema Moisturizer Regimen
- OTHER Cosmetic Moisturizer Regimen
Study Locations (2)
Colorado
- Thomas J. Stephens & Associates, Inc. - Colorado Springs
Texas
- Thomas J. Stephens and Associates, Inc. - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-03-27 |
| Est. Completion | 2016-06-13 |
| Phase | NA |
Sponsor
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies4 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673059
The ClinicalTrials.gov registry entry for NCT03673059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 10 other Microbiota trials with a reported enrollment target (30% lower). The listed sponsor is Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Microbiota appearing as the primary indexed condition, and to 2 interventions - of which OTC Eczema Moisturizer Regimen is the first listed.
NCT03673059 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Texas.
Frequently Asked Questions
What is clinical trial NCT03673059 about?
NCT03673059 is a clinical study titled "Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch". This was a multi-center, 14-day clinical use study with a 7-day regression period, being conducted to assess the changes in the skin microbiome with two moisturizers in female and male subjects 16-50 years of age with mild to moderate eczema that experienced a recent itch flare up.
What is the current status of trial NCT03673059?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-03-27. Estimated completion is 2016-06-13.
What conditions does trial NCT03673059 study?
This clinical trial studies the following conditions: Microbiota.
What interventions are being tested in trial NCT03673059?
The interventions under investigation include: OTC Eczema Moisturizer Regimen (DRUG), Cosmetic Moisturizer Regimen (OTHER).
Who is sponsoring clinical trial NCT03673059?
This trial is sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03673059 being conducted?
This trial has 2 study locations across Colorado, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbiota
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
Capillary Endoscopy Aspiration Catheter
RECRUITING · NA
-
Infant Restore: Efficacy of Microbiome Analysis and Education
ACTIVE NOT RECRUITING · NA
-
DASH INtervention to INvestigate the Gut
ACTIVE NOT RECRUITING · NA
-
Prebiotic Effects of Isomalto-oligosaccharide
COMPLETED · NA
-
Healthy Patients & Effect of Antibiotics
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.